Nutrition and depression

Geriatric Nutrition

Volumn , Issue , 2007, Pages 373-396

  Gebretsadik, Mehret ^a   Grossberg, George T ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866058417     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (123)

1. Mood disorders. In Kaplan and Sadock’s Synopsis of Psychiatry, 9th ed., Sadock BJ, Sadock VA, Eds., Philadelphia: Lippincott, Williams & Wilkins, 2003, pp. 534-590.
2. Holford B. Depression: the nutrition connection. Primary Care Mental Health 2003;1:9-16.
3. Benjamin J, Agam G, Levine J, Bersudsky Y, Kofman O, Belmaker RH. Inositol treatment in psychiatry. Psychopharmacol Bull 1995;31:167-175.
4. Palatnik A, Frolov K, Fux M, Benjamin J. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J Clin Psychopharmacol 2001;21:335-339.
5. Sontrop J, Campbell MK. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 2006;42:4-13.
6. Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry 2000;12:159-165.
7. Teimeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003;78:40-46.
8. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-479.
9. Horrobin DF, Manku M. Treatment of Depression with Ethyl-Eicosapentaenoate. Paper presented at International Society for the Study of Fatty Acids and Lipids (ISSFAL), 5th Congress, Montreal, Canada, May 8-11, 2002.
10. Mischoulon D, Fava M. Docosahexanoic acid and omega-3 fatty acids in depression. Psychiatr Clin North Am 2000;23:785-794.
11. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002;59:913-919.
12. Bhat RS, Chiu E, Jeste DV. Nutrition and geriatric psychiatry: a neglected field. Curr Opin Psychiatry 2005;18:609-614.
13. Benton D. Carbohydrate ingestion, blood glucose and mood. Neurosci Biobehav Rev 2002;26:293-308.
14. Chen CC, Chang CK, Chynn DA, McCorkle R. Dynamics of nutritional health in a community sample of American elders: a multidimensional approach using Roy adaptation model. ANS Adv Nurs Sci 2005;28:376-389.
15. Benton D, Donohoe RT. The effects of nutrients on mood. Public Health Nutr 1999;2:403-409.
16. Alpert JE, Fava M. Nutrition and depression: the role of folate. Nutr Rev 2003;55:145-149.
17. Bermudez OI, Dwyer J. Identifying elders at risk of malnutrition: a universal challenge. SCN News 1999;19:15-17.
18. Hajjar R, Kamel H, Denson K. Malnutrition in aging. Internet J Geriatr Gerontol 2004;1.
19. Kawakami K, Kadota J, Iida K, Shirai R, Abe K, Kohno S. Reduced immune function and malnutrition in the elderly. Tohoku J Exp Med 1999;187:157-171.
20. Lesourd B. Nutrition: a major factor influencing immunity in the elderly. J Nutr Health Aging 2004;8:28-37.
21. Lesourd B. Immune response during disease and recovery in the elderly. Proc Nutr Soc 1999;58:85-98.
22. Lesourd B, Mazari L. Nutrition and immunity in the elderly. Proc Nutr Soc 1999;58:685-695.
23. Irwin M. Immune correlates of depression. Adv Exp Med Biol 1999;461:1-24.
24. Evans DL, Pedersen CA, Folds JD. Major depression and immunity: preliminary evidence of decreased natural killer cell populations. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:739-748.
25. Irwin M, Patterson T, Smith TL, Caldwell C, Brown SA, Gillin JC, et al. Reeducation of immune function in life stress and depression. Biol Psychiatry 1990;27:22-30.
26. Miller GE, Cohen S, Herbert TB. Pathways linking major depression and immunity in ambulatory female patients. Psychosom Med 1999;61:850-860.
27. Buchanan CK, High KP. Nutrition, aging and infection. Clin Geriatr 2004;12:44-53.
28. Rovner BW, German PS, Brant LJ, Clark R, Burton L, Folstein MF. Depression and mortality in nursing homes. JAMA 1991;265:993-996.
29. Hybels CF, Blazer DG. Epidemiology of late life mental disorders. Clin Geriatr Med 2003;5(4):663-96.
30. Burke WJ, Wengel SP. Late life mood disorders. Clin Geriatr Med 2003;19:777-797.
31. Reynolds CF 3rd, Dew MA, Frank E, Begley AE, Miller MD, Cornes C, et al. Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. Am J Psychiatry 1998;155:795-799.
32. Conway CR, Steffens DC. Geriatric depression: further evidence for the ‘vascular depression’ hypothesis. Curr Opin Psychiatry 1999;12:463-470.
33. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 1997;54:915-922.
34. Steffens C, Krishnan R. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Soc Biol Psychiatry 1998;43:705-712.
35. Pohjasvaara T, Leppavuori A, Siira I, et al. Frequency and clinical determinants of poststroke depression. Stroke 1998;29:2311-2317.
36. Morris PL, Robinson RG, Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatry Med 1990;20:349-364.
37. Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 1999;61:26-37.
38. Birrer RB, Vemuri SP. Depression in later life: a diagnostic and therapeutic challenge. Am Fam Physician 2004;69(10):2375-82.
39. Cole MG, Dendukuri N. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 2003;160:1147-1156.
40. Boswell EB, Stoudemire A. Major depression in the primary care setting. Am J Med 1996;101:3S-9S.
41. von Ammon Cavanaugh S, Furlanetto LM, Creech SD, Powell LH. Medical illness, past depression, and present depression: a predictive triad for in-hospital mortality. Am J Psychiatry 2001;158:43-48.
42. Holly C, Murrell SA, Mast BT. Psychosocial and vascular risk factors for depression in the elderly. Am J Geriatr Psychiatry 2006;14:84-90.
43. Alexopoulos GS. Late life mood disorders. In Comprehesive Textbook of Geriatric Psychiatry, 3rd ed., Sadavoy J, Jarvik LF, Grossberg GT, Meyers BS, Eds. W.W. Norton and Company, New York, 2004, pp. 609-653.
44. Lapid MI, Rummans TA. Evaluation and management of geriatric depression in primary care. Mayo Clinic Proc 2003;78:1423-1429.
45. Huffman JB. Evaluating and treating unintentional weight loss in the elderly. Am Fam Physician 2002;65:640-650.
46. Splett PL, Roth-Yousey LL, Vogelzang JL. Medical nutrition therapy for the prevention and treatment of unintentional weight loss in residential healthcare facilities. J Am Diet Assoc 2003;103:352-362.
47. Gazewood JD, Mehr DR. Diagnosis and management of weight loss in the elderly. J Fam Pract 1998;47:19-25.
48. Reife CM. Involuntary weight loss. Med Clin North Am 1995;79:299-313.
49. Ryan C, Bryant E, Eleazer P, Rhodes A, Guest K. Unintentional weight loss in longterm care: predictor of mortality in the elderly. South Med J 1995;88:721-724.
50. Robertson RG, Montagnini M. Geriatric failure to thrive. Am Fam Physician 2004;70:343-350.
51. Alibahi SMH, Greenwood C, Payette H. An approach to the management of unintentional weight loss in elderly people. CMAJ 2005;172:773-780.
52. Fischer J, Johnson MA. Low body weight and weight loss in the aged. J Am Diet Assoc 1990;90:1697-1706.
53. Moriguti JC, Moriguti EKU, Ferriolli E, Cacao JDC, Junior NI, Marchini JS. Involuntary weight loss in elderly individuals: assessment and treatment. Sao Paulo Med J 2001;119:72-77.
54. Olsen-Noll CG, Bosworth MF. Anorexia and weight loss in the elderly. Causes range from loose dentures to debilitating illness. Postgrad Med 1989;85:140-144.
55. Chapman KM, Nelson RA. Loss of appetite: managing unwanted weight loss in the older patient. Geriatrics 1994;49:54-59.
56. van Staveren WA, de graaf C, de Groot LC. Regulation of appetite in frail persons. Clin Geriatr Med 2002;18:675-684.
57. Lankisch PG, Gerzmann M, Gerzmann J-F, Lehnick D. Unintentional weight loss: diagnosis and prognosis. The first prospective follow-up study from a secondary referral centre. J Intern Med 2001;249:41-46.
58. Lankisch P, Gerzmann M, Gerzmann JF, Lehnick D. Anorexia in older patients: its meaning and management. Geriatrics 1990;45:59-62, 65-66.
59. Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997;154:426-428.
60. American Psychiatric Association. Diagnositic Criteria from Diagnostic and Statistical Manual of Mental Disorders, fourth edition, Text Revision. Washington, DC, 2000, pp. 168-171.
61. Fischer J, Johnson MA. Low body weight and weight loss in the aged. J Am Diet Assoc 1990;90:1697-1706.
62. Joffe RT, Sokolov ST. Thyroid hormone treatment of primary unipolar depression: a review. Int J Neuropsychopharmacol 2000;3:143-147.
63. Benton D, Griffiths R, Haller J. Thiamine supplementation mood and cognitive functioning. Psychopharmacology 1997;129:66-71.
64. Moreno FA, Heninger GR, McGahuey CA, Delgado PL. Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes. Biol Psychiatry 2000;48:327-329.
65. Tiemeier H, Tuijl H, Hofman A, Meijer A, Kiliaan A, Breteler M. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 2002;159:2099-2101.
66. Morley JE. Anorexia in older persons: epidemiology and optimal treatment. Drugs Aging 1996;8:134-155.
67. Russel JD, Berg J, Lawrence JR. Anorexia tardive: a diagnosis of exclusion? Med J Aust 1988;148:199-201.
68. Joughin NA, Crisp AH, Gowers SG, Bhat AV. The clinical features of late onset anorexia nervosa. Postgrad Med J 1991;67:973-977.
69. Barbier D. Depression in the elderly. Principles of treatment. Presse Med 2001;30:341-344.
70. Raj A. Depression in the elderly: tailoring medical therapy to their special needs. Postgrad Med 2004;115:26-42.
71. Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life: consensus statement update. JAMA 1997;278:1186-1190.
72. Mulsant BH, Alexopoulos GS, Reynolds CF 3rd, Katz IR, Abrams R, Oslin D, Schulberg HC. PROSPECT Study Group. Pharmacological treatment of depression. Int J Geriatr Psychiatry 2001;Jun;16(6):558-92.
73. Masand P, Murray Gb, Pickett P. Psychostimulants in post-stroke depression. J Neuropsychiatry Clin Neurosci 1991;3:23-27.
74. Pickett P, Masand P, Murray GB. Psychostimulant treatment of geriatric depressive disorders secondary to medical illness. J Geriatr Psychiatry Neurol 1990;3:146-151.
75. Hollon SD. Psychotherapy research with older populations. Am J Geriatr Psychiatry 2003;11:7-8.
76. Hepple J. Psychotherapies with older people: an overview. Adv Psychiatr Treat 2004;10:371-377.
77. Dobson KS. A meta analysis of the efficacy of cognitive behavioral therapy in depression. J Consult Clin Psychol 1989;57:414-419.
78. Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N, Parr-Davis G, Sham P. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003;60:145-152.
79. Seltzer A, Roncari I, Garfinkel P. Effect of patient education on medication compliance. Can J Psychiatry 1980;25:638-645.
80. Hollon SD, Thase ME, Markowitz JC. Treatment and prevention of depression. Psychol Sci Public Interest 2002;3:39-77.
81. Mark D, Miller EF, Cornes C, Houck PR, Reynolds CF III. The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. Am J Geriatr Psychiatry 2003;11:97-102.
82. Brown WA. Brain stimulation methods for treating depression. http://www.appneurology. com/article/printableArticle.jhtml?articleId=181500920&printableArticle=true, Appl Neurol 2006;2.
83. Schlaeper T, Kosel M. Novel physical treatments for major depression: vagus nerve stimulation, transcranial magnetic stimulation and magnetic seizure therapy. Curr Opin Psychiatry 2004;17:15-20.
84. Greenberg RM, Keller CH. Electroconvulsive therapy: a selected review. Am J Geriatr Psychiatry 2005;13:268-281.
85. Bender KJ. Study expands on vagus nerve stimulation for depression. Psychiatr Times 2001;18. http://psychiatrictimes.com/p0104vagus.html.
86. Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: a multicenter study. Biol Psychiatry 2000;47:276-286.
87. Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005;58:347-354.
88. O’Reardon JP, Peshek AD, Romero R, Cristancho P. Neuromodulation and transcranial magnetic stimulation. Psychiatry 2006;3:30-40.
89. Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: a double blind, placebo-controlled trial. Arch Gen Psychiatry 2003;60:1002-1008.
90. Mosimann UP, Schmitt W, Greenberg BD, Kosel M, Muri RM, Berkhoff M, et al. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res 2004;126:123-133.
91. Fabre I, Galinowski A, Oppenheim C, Gallarda T, Meder JF, De Montigny C, et al. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial. Int J Geriatr Psychiatry 2004;19:833-842.
92. Ebmeier KP, Lappin JM. Electromagnetic stimulation in psychiatry. Adv Psychiatr Treat 2001;7:181-188.
93. Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci 2005;30:83-90.
94. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45:651-660.
95. Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 2002;32:451-478.
96. Lecrubier Y, Clerc G, Didi R, Kieser M. Efficacy of St. John’s wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 2002;159:1361-1366.
97. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St. John’s wort) in major depressive disorder: a randomized controlled trial. JAMA 2002;287:1807-1814.
98. van Gurp G, Meterissian GB, Haiek LN, McCusker J, Bellavance F. St. John’s wort or sertraline? Randomized controlled trial in primary care. Can Fam Physician 2002;48:905-912.
99. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr 2002;76:1158S-1161S.
100. CW Fetrow, JR Avila. Efficacy of the dietary supplement S-adenosyl-L-methionine. Ann Pharmacother 2001;35:1414-1425.
101. Saletu B, Anderer P, Di Padova C, Assandri A, Saletu-Zyhlarz GM. Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography. Am J Clin Nutr 2002;76:1162S-1171S.
102. Bottiglieri T. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside: molecular basis of a pleiotrophic molecule. Am J Clin Nutr 2002;76:1151S-1157S.
103. Pancheri P, Scapicchio P, Chiaie RD. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder. Int J Neuropsychopharmacol 2002;5:287-294.
104. Delle Chiaie R, Pancheri P, Scapicchio P. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr 2002;76:1172S-1176S.
105. Fava M, Giannelli A, Rapisarda V, Patralia A, Guaraldi GP. Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methionine. Psychiatry Res 1995;56:295-297.
106. Brottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1103-1112.
107. Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women’s Health and Aging Study. Am J Psychiatry 2000;157:715-721.
108. Fafouti M, Paparrigopoulos T, Liappas J, Mantouvalos V, Typaldou R, Christodoulou G. Mood disorder with mixed features due to vitamin B(12) and folate deficiency. Gen Hosp Psychiatry 2002;24:106-109.
109. Bell IR, Edman JS, Morrow FD, Marby DW, Mirages S, Perrone G, et al. B complex vitamin patterns in geriatric and young adult inpatients with major depression. J Am Geriatr Soc 1991;39:252-257.
110. Tiemeier H, Hofman A, Kiliaan Aj, Meijer J, Breteler MM. Vitamin E and depressive symptoms are not related. The Rotterdam Study. J Affect Disord 2002;72:79-83.
111. Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR. Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry 1999;45:1531-1532.
112. Almeida OP, Barclay L. Sex hormones and their impact on dementia and depression: a clinical perspective. Expert Opin Pharmacother 2001;2:527-535.
113. Margolese HC. The male menopause and mood: testosterone decline and depression in the aging male: is there a link? J Geriatr Psychiatry Neurol 2000;13:93-101.
114. Keller MB. Issues in treatment resistant depression. J Clin Psychiatry 2005;66(Suppl 8):5-12.
115. Berman RM, Narasimhan M, Charney DS. Treatment-refractory depression: definitions and characteristics (review). Depress Anxiety 1997;5:154-164.
116. Cadieux RJ. Practical management of treatment resistant depression. Am Fam Physician 1998;58:2059-2068.
117. Hirschfeld RM, Montgomery SA, Aguglia E, Amore M, Delgado PL, Gastpar M, et al. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry 2002;63:826-837.
118. Posternak MA, Zimmerman M. Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients. J Clin Psychiatry 2001;62:135-142.
119. Cowen PJ. New drugs old problems, revisiting pharmacological management of treatment resistant depression. Adv Psychiatr Treat 2005;11:19-27.
120. Morley JE. Anorexia and weight loss in older persons. J Gerontol A Biol Sci Med Sci 2003;58:131-137.
121. Sullivan DH. What do the serum proteins tell us about our elderly patients? J Gerontol Med Sci 2001;56A:M71-M74.
122. Reynolds R. Comparative efficacy of dronabinol and megestrol acetate. J Clin Oncol 2002;20:2912-2913.
123. Yuh S, Wu SY, Levin DM, Parker TS, Olson JS, Stevens MR, et al. Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome. J Nutr Health Aging 2000;4:246-251.